- Home
- LPTX vs GLBZ Comparison
LPTX vs GLBZ Comparison
Compare LPTX & GLBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- GLBZ
- Stock Information
- Founded
- LPTX 2011
- GLBZ 1949
- Country
- LPTX United States
- GLBZ United States
- Employees
- LPTX N/A
- GLBZ N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- GLBZ Major Banks
- Sector
- LPTX Health Care
- GLBZ Finance
- Exchange
- LPTX Nasdaq
- GLBZ Nasdaq
- Market Cap
- LPTX 11.1M
- GLBZ 12.4M
- IPO Year
- LPTX N/A
- GLBZ N/A
- Fundamental
- Price
- LPTX $0.75
- GLBZ N/A
- Analyst Decision
- LPTX Hold
- GLBZ
- Analyst Count
- LPTX 1
- GLBZ 0
- Target Price
- LPTX N/A
- GLBZ N/A
- AVG Volume (30 Days)
- LPTX 7.6M
- GLBZ 4.3K
- Earning Date
- LPTX 11-12-2025
- GLBZ 10-30-2025
- Dividend Yield
- LPTX N/A
- GLBZ N/A
- EPS Growth
- LPTX N/A
- GLBZ N/A
- EPS
- LPTX N/A
- GLBZ 0.01
- Revenue
- LPTX N/A
- GLBZ $12,483,000.00
- Revenue This Year
- LPTX N/A
- GLBZ N/A
- Revenue Next Year
- LPTX N/A
- GLBZ N/A
- P/E Ratio
- LPTX N/A
- GLBZ $456.37
- Revenue Growth
- LPTX N/A
- GLBZ 8.71
- 52 Week Low
- LPTX $0.22
- GLBZ $3.89
- 52 Week High
- LPTX $4.79
- GLBZ $6.99
- Technical
- Relative Strength Index (RSI)
- LPTX 63.63
- GLBZ 57.77
- Support Level
- LPTX $0.46
- GLBZ $4.60
- Resistance Level
- LPTX $0.98
- GLBZ $4.75
- Average True Range (ATR)
- LPTX 0.11
- GLBZ 0.10
- MACD
- LPTX 0.03
- GLBZ 0.01
- Stochastic Oscillator
- LPTX 51.58
- GLBZ 88.64
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About GLBZ Glen Burnie Bancorp
Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.